Hereditary elliptocytosis (HE) is a group of disorders characterized by abnormal erythrocyte shapes that occur mainly in individuals of African and Mediterranean ancestry. In Korea, HE is the cause of 1.4% (6/431) cases of hereditary hemolytic anemia (HHA) \[[@B1]\]. HE causes mechanical weakness or fragility of the erythrocytic membrane skeleton because of defects in spectrin or protein 4.1. The erythrocyte spectrin is a scaffold protein composed of 2 subunits, α- and β-spectrin, maintains the cellular shape, regulates the lateral mobility of integral membrane proteins, and provides structural support for the lipid bilayer \[[@B2], [@B3]\]. The mutations responsible for HE are located in several genes encoding membrane proteins, including protein 4.1, α-spectrin, β-spectrin, band 3, and glycophorin C. Mutations in α-spectrin are the most common, occurring in 65% of the HE cases, followed by mutations in β-spectrin (30%) and protein 4.1 (5%) \[[@B4]\].

We studied a Korean family presenting with HE. To our knowledge, this is the first report to describe a family of Korean descent diagnosed with HE by molecular analysis. A 28-yr-old woman visited our hospital and was found to have anemia during a routine health screening. She did not complain of symptoms related to anemia. Abdominal ultrasonography revealed splenomegaly (craniocaudal length, 13.8 cm). Marked anisopoikilocytosis, including elliptocytes, schistocytes, and teardrop cells, were detected on a peripheral blood smear ([Fig. 1A](#F1){ref-type="fig"}). A complete blood count revealed pancytopenia (white blood cell count, 3.88×10^9^/L; hemoglobin level, 7.6 g/dL; and platelet count, 95×10^9^/L). Red cell indices revealed macrocytic normochromic anemia (red blood cell count, 2.20×10^12^/L; reticulocyte count, 0.968×10^12^/L; hematocrit value, 24%; mean corpuscular volume, 109.1 fL; and mean corpuscular hemoglobin concentration, 31.7%). We ruled out iron deficiency or megaloblastic anemia based on the following laboratory findings: serum iron level, 96 µg/dL (reference range: 50-150 µg/dL); ferritin level, 104 ng/mL (10-120 ng/mL); total iron-binding capacity, 204 µg/dL (250-450 µg/dL); vitamin B~12~ concentration, \>1,500 pg/mL (180-914 pg/mL); and folate concentration, 7.47 ng/mL (3.1-19.9 ng/mL). The serum concentrations of total bilirubin (1.02 mg/dL), haptoglobin (\<30 mg/dL), and lactate dehydrogenase (556 U/L) confirmed the presence of a hemolytic process. Bone marrow studies showed hypercellularity and erythroid hyperplasia with G:E ratio of 0.67:1 ([Fig. 1B](#F1){ref-type="fig"}), and cytogenetic studies revealed a normal karyotype (46,XX\[20\]).

The patient\'s mother was also diagnosed with anemia and elliptocytosis based on peripheral blood films. Therefore, we suspected familial transmission of elliptocytosis. At the time of this study, the patient was pregnant, and after delivery, the peripheral blood smears from the newborn were analyzed, which revealed elliptocytosis. Autosomal dominant inheritance was suspected, and spectrin-gene-mutation analysis of the patient and her family (affected mother, her baby, and unaffected brother) was performed. Genomic DNA was prepared using the QIAamp DNA Mini Kit (Qiagen, Hamburg, Germany). All coding exons and flanking intronic sequences of the spectrin, alpha, erythrocytic 1 gene (*SPTA1*) and spectrin, beta, erythrocytic gene (*SPTB*) (reference cDNA sequence, NM_003126.2 and NM_000347.5) were amplified and sequenced using primers as previously described \[[@B5], [@B6]\]. In particular, the region encoding exon 2 of *SPTA1* was amplified by PCR using the following forward and reverse primers: 5\'-GGTCCAACATGAGTAAACACCTTGACA-3\' and 5\'-TCTCACCTCTCCAACTTCATAAGGGA-3\', respectively. Direct sequencing of the *SPTA1* gene revealed a heterozygous missense mutation in exon 2, resulting in a C to T substitution at nucleotide position 121 and an amino acid change of arginine to tryptophan (c.121C\>T; p.Arg41Trp) at amino acid residue 41 in the alpha l domain in both the patient and her baby ([Fig. 2](#F2){ref-type="fig"}). This missense mutation induces spectrin Tunis, which reduces the binding affinity for the spectrin tetramer assembly. Spectrin Tunis was designated as α^I/78^ because of its location in the first alpha domain of *SPTA1* \[[@B7]\]. In addition, we analyzed the sequences of *SLC4A1* (solute carrier family 4, anion exchanger, member 1) and *EPB41* (erythrocyte membrane protein band 4.1) but found no mutations in these genes.

HE is a group of disorders characterized by the presence of elliptical erythrocytes on a peripheral blood smear. Disorders in which elliptocytosis may be prominent also include iron deficiency, leukemia, megaloblastic anemia, myelofibrosis, myelophthisic anemia, myelodysplastic syndromes, polycythemia, pyruvate kinase deficiency, and sickle cell disease \[[@B8]\]. Examination of family history is the most reliable method for differentiating HE from other disorders, in which elliptocytosis may be prominent \[[@B9]\]. Biochemical and mechanical methods can be used to determine defects in erythrocyte membrane proteins, such as spectrin or protein 4.1. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) is used in qualitative and quantitative detection of alterations in membrane proteins. In addition, assessment of thermal sensitivity, *in vitro* studies of spectrin self-association, and trypsin peptide mapping of spectrin can assist in the diagnosis of HE \[[@B8]\].

Currently, many genetic studies have been designed to detect various genetic mutations in HE \[[@B9]\]. All spectrin mutations associated with HE are located in or near self-association sites between the α- or β-chains. As a result, the corresponding subset of HE is derived from an impaired self-association process, which is a critical process for red cell deformability. Erythroid spectrin α- and β-chains are encoded by the *SPTA1* gene on 1q22-23 and the *SPTB* gene on 14q23-24.2, respectively. Many *SPTA1* gene mutations are single-nucleotide substitutions, whereas others are intronic mutations that cause errors in gene splicing \[[@B10]-[@B14]\]. *SPTA1*-related HE is characterized by marked clinical, biochemical, and genetic heterogeneity. Clinically, the presentation varies from a nearly complete absence of symptoms to transfusion-dependent hemolytic anemia. The location of the change within the spectrin α-chain and the homozygous or compound heterozygous status affect clinical manifestations. Remarkably, both mildly and severely affected patients are found in almost all affected kindred \[[@B15]\].

In a review of Korean literature on HHA, we found 15 case reports on HE, including our case \[[@B1], [@B16]\]. Red-cell-membrane defects were the most common (88.6%) in HHA. Hereditary spherocytosis accounted for 87.2% of red-cell-membrane defects, whereas HE accounted for 1.4% of the defects \[[@B1]\]. Lee et al. \[[@B16]\] detected protein 4.1 deficiency in 6 Korean patients with HE by using SDS-PAGE analysis.

In this study, we identified the first *SPTA1* gene mutation in a Korean family diagnosed with HE. The heterozygous c.121C\>T mutation induces an amino acid change p.Arg41Trp in the α1 domain of the α-spectrin protein. Morlé et al. \[[@B7]\] first described this mutation and called this disease spectrin Tunis, which causes asymptomatic HE (OMIM 130600) in patients with a heterozygous mutation. A variant was also found in a white North African man and his mother. The α^I/78^ variant (rs121918640) exhibits reduced binding affinity, generates an abnormal spectrin protein with an αI 78-kDa fragment, and results in a mutation, which partially destroys the ability of the dimer to form a tetramer \[[@B7]\]. Most spectrin mutations are private, and it is interesting that spectrin Tunis was detected in a Korean family. However, some mutations in *SPTA1* are encountered more frequently than originally thought, such as the case of a mutation affecting codon α28, which contains a CpG hot spot \[[@B17]\]. The CpG dinucleotide has also been implicated in a number of band 3 gene hot spots, most of which encode arginine (CGN, N indicating any nucleotide). The mutation resulting in spectrin Tunis occurs in the CpG dinucleotide at codon 41, which also encodes arginine (CGG).

The patient who transmits the production-defective spectrin allele is clinically normal with unremarkable erythrocyte morphology because α-spectrin is normally synthesized in a 2- to 3-fold excess, and the output from a single normal α-spectrin allele is sufficient to maintain membrane integrity \[[@B18], [@B19]\]. Because this α-spectrin variant is related to asymptomatic HE in a heterozygous state, the outcomes may include mild elliptocytosis in the proband and her baby. To our knowledge, this is the first report on HE confirmed by mutation analysis in a Korean family. More data need to be collected from HE patients to understand the genetic distributions and genotype-phenotype correlations.
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![(A) Marked anisopoikilocytosis, including elliptocytosis, schistocytes, and teardrop cells, on a peripheral blood smear. (B) Bone marrow aspirates showing hypercellularity and erythroid hyperplasia (Wright-Giemsa Stain, ×1,000).](alm-33-386-g001){#F1}
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